Page 25 - Technology Network News Today

IMAX (NYSE:IMAX – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday. A number of other equities analysts also recently issued reports on IMAX. Wedbush reiterated an “outperform” rating and set a $26.00 price objective on shares […]

Plant biologists report that a species of tree fern found only in Panama reanimates its own dead leaf fronds, converting them into root structures that feed the mother plant.

IMAX (NYSE:IMAX – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Saturday. A number of other brokerages have also weighed in on IMAX. The Goldman Sachs Group lowered their target price on IMAX from $15.00 to $13.00 and set […]

A single dose of the typhoid conjugate vaccine, Typbar TCV®, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study.

In a study a team of scientists reports that a tiny and seemingly innocuous invasive ant species is changing tree cover in an East African wildlife area, making it harder for lions to hunt its preferred prey, zebra.

EEG data has shown how brain connectivity is enhanced when writing by hand compared to typing on a keyboard, which has implications for memory and learning, especially in classrooms.

Exposure to toxic heavy metals can lead to various harmful effects on the body. New research suggests middle-aged women in particular may face heightened risks.

Research has found that the quality of Carbonic maceration wines can be increased by using an unconventional yeast that considerably improves their organoleptic properties.

Princeton researchers have learned to harness the gossamer scaffolding that maintains the structure of living cells and used it to develop a nanotechnology platform. The technique eventually could lead to advances in soft robotics and new medicines.

Researchers have developed an oral form of insulin that lowers glucose levels in animal models. The oral insulin, encased in a nano-carrier that delivers insulin to the liver, is expected to begin human trials in 2025.